Lower insulin clearance is associated with increased risk of type 2 diabetes in Native Americans.
Adult
Arizona
/ epidemiology
Biomarkers
/ blood
Blood Glucose
/ metabolism
Cross-Sectional Studies
Diabetes Mellitus, Type 2
/ blood
Female
Glucose Clamp Technique
Glucose Tolerance Test
Humans
Incidence
Indians, North American
Insulin
/ blood
Male
Metabolic Clearance Rate
Predictive Value of Tests
Prognosis
Prospective Studies
Risk Assessment
Risk Factors
Time Factors
Young Adult
Acute insulin response
Hyperinsulinaemic–euglycaemic clamp
Insulin clearance
OGTT
Type 2 diabetes
Journal
Diabetologia
ISSN: 1432-0428
Titre abrégé: Diabetologia
Pays: Germany
ID NLM: 0006777
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
received:
07
08
2020
accepted:
22
10
2020
pubmed:
7
1
2021
medline:
16
2
2022
entrez:
6
1
2021
Statut:
ppublish
Résumé
Impaired insulin clearance is implicated in the pathogenesis of type 2 diabetes, but prospective evidence remains limited. Therefore, we sought to identify factors associated with the metabolic clearance rate of insulin (MCRI) and to investigate whether lower MCRI is associated with increased risk of incident type 2 diabetes. From a longitudinal cohort, 570 adult Native Americans without diabetes living in the Southwestern United States were characterised at baseline and 448 participants were monitored over a median follow-up period of 7.9 years with 146 (32%) incident cases of diabetes identified (fasting plasma glucose ≥7.0 mmol/l, 2 h plasma glucose [2-h PG] ≥11.1 mmol/l, or clinical diagnosis). At baseline, participants underwent dual-energy x-ray absorptiometry or hydrodensitometry to assess body composition, a 75 g OGTT, an IVGTT to assess acute insulin response (AIR), and a hyperinsulinaemic-euglycaemic clamp to assess MCRI and insulin action (M). In adjusted linear models, MCRI was inversely associated with body fat percentage (r = -0.35), fasting plasma insulin (r = -0.55) and AIR (r = -0.22), and positively associated with M (r = 0.17; all p < 0.0001). In multivariable Cox proportional hazard models, lower MCRI was associated with an increased risk of diabetes after adjustment for age, sex, heritage, body fat percentage, AIR, M, fasting plasma glucose, 2-h PG, and fasting plasma insulin (HR per one-SD difference in MCRI: 0.77; 95% CI 0.61, 0.98; p = 0.03). Lower MCRI is associated with an unfavourable metabolic phenotype and is associated with incident type 2 diabetes independent of established risk factors. ClinicalTrials.gov NCT00339482; NCT00340132.
Identifiants
pubmed: 33404681
doi: 10.1007/s00125-020-05348-5
pii: 10.1007/s00125-020-05348-5
doi:
Substances chimiques
Biomarkers
0
Blood Glucose
0
Insulin
0
Banques de données
ClinicalTrials.gov
['NCT00339482', 'NCT00340132']
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
914-922Références
Weyer C, Hanson RL, Tataranni PA, Bogardus C, Pratley RE (2000) A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. Diabetes 49(12):2094–2101. https://doi.org/10.2337/diabetes.49.12.2094
doi: 10.2337/diabetes.49.12.2094
pubmed: 11118012
Goodarzi MO, Cui J, Chen YD, Hsueh WA, Guo X, Rotter JI (2011) Fasting insulin reflects heterogeneous physiological processes: role of insulin clearance. Am J Physiol Endocrinol Metab 301(2):E402–E408. https://doi.org/10.1152/ajpendo.00013.2011
doi: 10.1152/ajpendo.00013.2011
pubmed: 21632466
pmcid: 3154529
Tokarz VL, MacDonald PE, Klip A (2018) The cell biology of systemic insulin function. J Cell Biol 217(7):2273–2289. https://doi.org/10.1083/jcb.201802095
doi: 10.1083/jcb.201802095
pubmed: 29622564
pmcid: 6028526
Duckworth WC, Bennett RG, Hamel FG (1998) Insulin degradation: progress and potential. Endocr Rev 19(5):608–624. https://doi.org/10.1210/edrv.19.5.0349
doi: 10.1210/edrv.19.5.0349
pubmed: 9793760
DeFronzo R (1988) Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37(6):667–687. https://doi.org/10.2337/diab.37.6.667
doi: 10.2337/diab.37.6.667
pubmed: 3289989
Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104(6):787–794. https://doi.org/10.1172/JCI7231
doi: 10.1172/JCI7231
pubmed: 10491414
pmcid: 408438
Meistas MT, Margolis S, Kowarski AA (1983) Hyperinsulinemia of obesity is due to decreased clearance of insulin. Am J Phys 245(2):E155–E159. https://doi.org/10.1152/ajpendo.1983.245.2.E155
doi: 10.1152/ajpendo.1983.245.2.E155
Jung SH, Jung CH, Reaven GM, Kim SH (2018) Adapting to insulin resistance in obesity: role of insulin secretion and clearance. Diabetologia 61(3):681–687. https://doi.org/10.1007/s00125-017-4511-0
doi: 10.1007/s00125-017-4511-0
pubmed: 29196782
Jones CN, Pei D, Staris P, Polonsky KS, Chen YD, Reaven GM (1997) Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals. J Clin Endocrinol Metab 82(6):1834–1838. https://doi.org/10.1210/jcem.82.6.3979
doi: 10.1210/jcem.82.6.3979
pubmed: 9177392
Ader M, Stefanovski D, Kim SP et al (2014) Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dog. Obesity (Silver Spring) 22(5):1238–1245. https://doi.org/10.1002/oby.20625
doi: 10.1002/oby.20625
Bergman RN, Piccinini F, Kabir M, Kolka CM, Ader M (2019) Hypothesis: role of reduced hepatic insulin clearance in the pathogenesis of type 2 diabetes. Diabetes 68(9):1709–1716. https://doi.org/10.2337/db19-0098
doi: 10.2337/db19-0098
pubmed: 31431441
pmcid: 6702636
Watada H, Tamura Y (2017) Impaired insulin clearance as a cause rather than a consequence of insulin resistance. J Diabetes Investig 8(6):723–725. https://doi.org/10.1111/jdi.12717
doi: 10.1111/jdi.12717
pubmed: 28752566
pmcid: 5668474
Kabir M, Catalano KJ, Ananthnarayan S et al (2005) Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Am J Physiol Endocrinol Metab 288(2):E454–E461. https://doi.org/10.1152/ajpendo.00203.2004
doi: 10.1152/ajpendo.00203.2004
pubmed: 15522994
Lee CC, Haffner SM, Wagenknecht LE et al (2013) Insulin clearance and the incidence of type 2 diabetes in Hispanics and African Americans: the IRAS Family Study. Diabetes Care 36(4):901–907. https://doi.org/10.2337/dc12-1316
doi: 10.2337/dc12-1316
pubmed: 23223351
pmcid: 3609510
Knowler WC, Bennett PH, Hamman RF, Miller M (1978) Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 108(6):497–505. https://doi.org/10.1093/oxfordjournals.aje.a112648
doi: 10.1093/oxfordjournals.aje.a112648
pubmed: 736028
Lillioja S, Mott DM, Spraul M et al (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329(27):1988–1992. https://doi.org/10.1056/NEJM199312303292703
doi: 10.1056/NEJM199312303292703
pubmed: 8247074
Genuth S, Alberti KG, Bennett P et al (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26(11):3160–3167. https://doi.org/10.2337/diacare.26.11.3160
doi: 10.2337/diacare.26.11.3160
pubmed: 14578255
Knowler WC, Saad MF, Pettitt DJ, Nelson RG, Bennett PH (1993) Determinants of diabetes mellitus in the Pima Indians. Diabetes Care 16(1):216–227. https://doi.org/10.2337/diacare.16.1.216
doi: 10.2337/diacare.16.1.216
pubmed: 8422779
Goldman RF, Buskirk ER (1961) Body volume measurement by underwater weighing: description of a method. Techniques for measuring body composition. National Academy of Science–National Research Council, Washington, DC, pp. 78–89
Tataranni PA, Ravussin E (1995) Use of dual-energy x-ray absorptiometry in obese individuals. Am J Clin Nutr 62(4):730–734. https://doi.org/10.1093/ajcn/62.4.730
doi: 10.1093/ajcn/62.4.730
pubmed: 7572700
Schwartz MW, Boyko EJ, Kahn SE, Ravussin E, Bogardus C (1995) Reduced insulin secretion: an independent predictor of body weight gain. J Clin Endocrinol Metab 80(5):1571–1576. https://doi.org/10.1210/jcem.80.5.7745002
doi: 10.1210/jcem.80.5.7745002
pubmed: 7745002
Chen M, Porte D (1976) The effect of rate and dose of glucose infusion on the acute insulin response in man. J Clin Endocrinol Metab 42(6):1168–1175. https://doi.org/10.1210/jcem-42-6-1168
doi: 10.1210/jcem-42-6-1168
pubmed: 932179
Lillioja S, Mott DM, Howard BV et al (1988) Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318(19):1217–1225. https://doi.org/10.1056/NEJM198805123181901
doi: 10.1056/NEJM198805123181901
pubmed: 3283552
DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Phys 237(3):E214–E223. https://doi.org/10.1152/ajpendo.1979.237.3.E214
doi: 10.1152/ajpendo.1979.237.3.E214
Steele R (1959) Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 82:420–430. https://doi.org/10.1111/j.1749-6632.1959.tb44923.x
doi: 10.1111/j.1749-6632.1959.tb44923.x
pubmed: 13833973
Castillo MJ, Scheen AJ, Letiexhe MR, Lefèbvre PJ (1994) How to measure insulin clearance. Diabetes Metab Rev 10(2):119–150. https://doi.org/10.1002/dmr.5610100205
doi: 10.1002/dmr.5610100205
pubmed: 7956676
Goodarzi MO, Taylor KD, Guo X et al (2005) Variation in the gene for muscle-specific AMP deaminase is associated with insulin clearance, a highly heritable trait. Diabetes 54(4):1222–1227. https://doi.org/10.2337/diabetes.54.4.1222
doi: 10.2337/diabetes.54.4.1222
pubmed: 15793265
Kim MK, Reaven GM, Chen YD, Kim E, Kim SH (2015) Hyperinsulinemia in individuals with obesity: role of insulin clearance. Obesity (Silver Spring) 23(12):2430–2434. https://doi.org/10.1002/oby.21256
doi: 10.1002/oby.21256
Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Jarvinen H (2008) Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. Gastroenterology 135(1):122–130. https://doi.org/10.1053/j.gastro.2008.03.021
doi: 10.1053/j.gastro.2008.03.021
pubmed: 18474251
Leibiger IB, Leibiger B, Berggren P-O (2008) Insulin signaling in the pancreatic β-cell. Annu Rev Nutr 28(1):233–251. https://doi.org/10.1146/annurev.nutr.28.061807.155530
doi: 10.1146/annurev.nutr.28.061807.155530
pubmed: 18481923
Anderwald C, Tura A, Grassi A et al (2011) Insulin infusion during normoglycemia modulates insulin secretion according to whole-body insulin sensitivity. Diabetes Care 34(2):437–441. https://doi.org/10.2337/dc10-1137
doi: 10.2337/dc10-1137
pubmed: 21216852
pmcid: 3024363
Herbert V, Lau KS, Gottlieb CW, Bleicher SJ (1965) Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25(10):1375–1384. https://doi.org/10.1210/jcem-25-10-1375
doi: 10.1210/jcem-25-10-1375
pubmed: 5320561
Yalow RS, Berson SA (1996) Immunoassay of endogenous plasma insulin in man. Obes Res 4(6):583–600. https://doi.org/10.1002/j.1550-8528.1996.tb00274.x
doi: 10.1002/j.1550-8528.1996.tb00274.x
pubmed: 8946445
Lin DY, Wei LJ, Ying Z (1993) Checking the Cox model with cumulative sums of martingale-based residuals. Biometrika 80(3):557–572. https://doi.org/10.2307/2337177
doi: 10.2307/2337177
Lin DY, Fleming TR, De Gruttola V (1997) Estimating the proportion of treatment effect explained by a surrogate marker. Stat Med 16(13):1515–1527. https://doi.org/10.1002/(sici)1097-0258(19970715)16:13<1515::aid-sim572>3.0.co;2-1
doi: 10.1002/(sici)1097-0258(19970715)16:13<1515::aid-sim572>3.0.co;2-1
pubmed: 9249922
Pivovarova O, Bernigau W, Bobbert T et al (2013) Hepatic insulin clearance is closely related to metabolic syndrome components. Diabetes Care 36(11):3779–3785. https://doi.org/10.2337/dc12-1203
doi: 10.2337/dc12-1203
pubmed: 24026549
pmcid: 3816867
Amato MC, Vesco R, Vigneri E, Ciresi A, Giordano C (2015) Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance. J Endocrinol Investig 38(12):1319–1326. https://doi.org/10.1007/s40618-015-0372-x
doi: 10.1007/s40618-015-0372-x
Kotronen A, Vehkavaara S, Seppala-Lindroos A, Bergholm R, Yki-Jarvinen H (2007) Effect of liver fat on insulin clearance. Am J Physiol Endocrinol Metab 293(6):E1709–E1715. https://doi.org/10.1152/ajpendo.00444.2007
doi: 10.1152/ajpendo.00444.2007
pubmed: 17895288
Fosam A, Sikder S, Abel BS et al (2020) Reduced insulin clearance and insulin degrading enzyme activity contribute to hyperinsulinemia in African Americans. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgaa070
Piccinini F, Polidori DC, Gower BA, Bergman RN (2017) Hepatic but not extrahepatic insulin clearance is lower in African American than in European American women. Diabetes 66(10):2564–2570. https://doi.org/10.2337/db17-0413
doi: 10.2337/db17-0413
pubmed: 28710139
pmcid: 5606316
Jensen MD, Nielsen S, Gupta N, Basu R, Rizza RA (2012) Insulin clearance is different in men and women. Metabolism 61(4):525–530. https://doi.org/10.1016/j.metabol.2011.08.009
doi: 10.1016/j.metabol.2011.08.009
pubmed: 22000585
Lorenzo C, Hanley AJ, Wagenknecht LE et al (2013) Relationship of insulin sensitivity, insulin secretion, and adiposity with insulin clearance in a multiethnic population: the insulin Resistance Atherosclerosis study. Diabetes Care 36(1):101–103. https://doi.org/10.2337/dc12-0101
doi: 10.2337/dc12-0101
pubmed: 22933441
Semnani-Azad Z, Johnston LW, Lee C et al (2019) Determinants of longitudinal change in insulin clearance: the Prospective Metabolism and Islet Cell Evaluation cohort. BMJ Open Diabetes Res Care 7(1):e000825. https://doi.org/10.1136/bmjdrc-2019-000825
doi: 10.1136/bmjdrc-2019-000825
pubmed: 31803485
pmcid: 6887510
Fiorentino TV, Sesti F, Succurro E et al (2018) Higher serum levels of uric acid are associated with a reduced insulin clearance in non-diabetic individuals. Acta Diabetol 55(8):835–842. https://doi.org/10.1007/s00592-018-1153-8
doi: 10.1007/s00592-018-1153-8
pubmed: 29774469
Ghadieh HE, Russo L, Muturi HT et al (2019) Hyperinsulinemia drives hepatic insulin resistance in male mice with liver-specific Ceacam1 deletion independently of lipolysis. Metabolism 93:33–43. https://doi.org/10.1016/j.metabol.2019.01.008
doi: 10.1016/j.metabol.2019.01.008
pubmed: 30664851
pmcid: 6401268
Hennes MM, Dua A, Kissebah AH (1997) Effects of free fatty acids and glucose on splanchnic insulin dynamics. Diabetes 46(1):57–62. https://doi.org/10.2337/diab.46.1.57
doi: 10.2337/diab.46.1.57
pubmed: 8971082
Vozarova B, Stefan N, Lindsay RS et al (2002) High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51(6):1889–1895. https://doi.org/10.2337/diabetes.51.6.1889
doi: 10.2337/diabetes.51.6.1889
pubmed: 12031978
Piccinini F, Bergman RN (2020) The measurement of insulin clearance. Diabetes Care 43(9):2296–2302. https://doi.org/10.2337/dc20-0750
doi: 10.2337/dc20-0750
pubmed: 32910777